Close Menu

NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Wednesday that its first quarter revenues increased 27 percent year over year.

For the three months ended March 31, the San Diego-based liquid biopsy firm saw $1.0 million in revenues compared to $806,943 a year ago. These included about $976,000 in commercial test revenues and $42,000 from development services testing. The firm posted $6,000 in other revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.

Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.

Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.

In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.